GlassScriptPhysician profile
Tamara Mendez Romero
NPI 1225413503
$3,260.82
in general payments reported to CMS, 2019-2025
18 companies · $721 in 2025
The $721 reported for 2025 was more than what 85% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $707 · 2020: $163 · 2021: $47.93 · 2022: $166 · 2023: $423 · 2024: $1,033 · 2025: $721.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,590 · Entertainment: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,589.95 |
| Entertainment | $587.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optos, INC. | $587.93 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Alcon Vision LLC | $460.96 | 2020-2025 | Total30, Eysuvis, Dailies Total1 |
| Tarsus Pharmaceuticals, INC. | $353.82 | 2024-2025 | Xdemvy |
| Allergan, INC. | $269.22 | 2019-2022 | |
| Bausch & Lomb Americas INC. | $260.77 | 2022-2024 | Infuse, Miebo, Xiidra |
| Sun Pharmaceutical Industries INC. | $205.69 | 2019-2021 | |
| Johnson & Johnson Vision Care, INC. | $192.26 | 2019-2024 | Acuvue |
| Glaukos Corporation | $181.88 | 2025 | Photrexa Viscous and Photrexa |
| Dompe US, INC. | $167.04 | 2019-2025 | Oxervate |
| Sight Sciences, INC. | $111.75 | 2022-2025 | Omni Surgical System |
| Shire North American Group INC | $109.17 | 2019 | |
| Novartis Pharmaceuticals Corporation | $98.96 | 2019-2023 | |
| Oyster Point Pharma, INC. | $89.14 | 2024-2025 | Tyrvaya, Ryzumvi |
| Coopervision INC. | $60.95 | 2023-2024 | Myday Contact Lens |
| Aerie Pharmaceuticals, INC. | $57.89 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $24.27 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $17.48 | 2019 | |
| Visioneering Technologies, INC. | $11.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Mendez Romero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.